In this Momentum Discussion Podcast episode, Dr. Armen J. Moughamian, a neurologist who cares for people with neurodegenerative brain illnesses, including Alzheimer’s disease and other dementias, explains anti-amyloid therapy for Alzheimer’s disease and mild cognitive impairment. He describes who may benefit from these therapies, discusses their efficacy and safety, and explains the importance of early detection of cognitive impairment. Dr. Moughamian also provides important insights into how primary care teams can help ensure that individuals who might be candidates for anti-amyloid therapies are well prepared for timely referrals to a neurologist.

Download the Transcript

Speaker

Armen J. Moughamian, MD, PhD, Medical Director at the Ray Dolby Brain Health Center, Division Chief of Neurology, Vice Chair of Neuroscience at the California Pacific Medical Center

Host

Jennifer L. Pettis, MS, RN, CNE, Director, Strategic Alliances, Gerontological Society of America

This podcast episode is supported by Eisai. Content was developed by Gerontological Society of America (GSA).